204 related articles for article (PubMed ID: 30941100)
1. Phosphodiesterases and cAMP Pathway in Pituitary Diseases.
Bizzi MF; Bolger GB; Korbonits M; Ribeiro-Oliveira A
Front Endocrinol (Lausanne); 2019; 10():141. PubMed ID: 30941100
[TBL] [Abstract][Full Text] [Related]
2. Reduced protein expression of the phosphodiesterases PDE4A4 and PDE4A8 in AIP mutation positive somatotroph adenomas.
Bizzi MF; Pinheiro SVB; Bolger GB; Schweizer JROL; Giannetti AV; Dang MN; Ribeiro-Oliveira A; Korbonits M
Mol Cell Endocrinol; 2018 Nov; 476():103-109. PubMed ID: 29729370
[TBL] [Abstract][Full Text] [Related]
3. cAMP-specific PDE4 phosphodiesterases and AIP in the pathogenesis of pituitary tumors.
Bolger GB; Bizzi MF; Pinheiro SV; Trivellin G; Smoot L; Accavitti MA; Korbonits M; Ribeiro-Oliveira A
Endocr Relat Cancer; 2016 May; 23(5):419-31. PubMed ID: 27267386
[TBL] [Abstract][Full Text] [Related]
4. Role of Phosphodiesterases on the Function of Aryl Hydrocarbon Receptor-Interacting Protein (AIP) in the Pituitary Gland and on the Evaluation of AIP Gene Variants.
Hernández-Ramírez LC; Trivellin G; Stratakis CA
Horm Metab Res; 2017 Apr; 49(4):286-295. PubMed ID: 28427099
[TBL] [Abstract][Full Text] [Related]
5. The role of the aryl hydrocarbon receptor-interacting protein gene in familial and sporadic pituitary adenomas.
Leontiou CA; Gueorguiev M; van der Spuy J; Quinton R; Lolli F; Hassan S; Chahal HS; Igreja SC; Jordan S; Rowe J; Stolbrink M; Christian HC; Wray J; Bishop-Bailey D; Berney DM; Wass JA; Popovic V; Ribeiro-Oliveira A; Gadelha MR; Monson JP; Akker SA; Davis JR; Clayton RN; Yoshimoto K; Iwata T; Matsuno A; Eguchi K; Musat M; Flanagan D; Peters G; Bolger GB; Chapple JP; Frohman LA; Grossman AB; Korbonits M
J Clin Endocrinol Metab; 2008 Jun; 93(6):2390-401. PubMed ID: 18381572
[TBL] [Abstract][Full Text] [Related]
6. Role of the aryl hydrocarbon receptor-interacting protein in familial isolated pituitary adenoma.
Cain JW; Miljic D; Popovic V; Korbonits M
Expert Rev Endocrinol Metab; 2010 Sep; 5(5):681-695. PubMed ID: 30764022
[TBL] [Abstract][Full Text] [Related]
7. Chaperones, somatotroph tumors and the cyclic AMP (cAMP)-dependent protein kinase (PKA) pathway.
Schernthaner-Reiter MH; Trivellin G; Stratakis CA
Mol Cell Endocrinol; 2020 Jan; 499():110607. PubMed ID: 31586652
[TBL] [Abstract][Full Text] [Related]
8. Molecular genetics of the aip gene in familial pituitary tumorigenesis.
Tahir A; Chahal HS; Korbonits M
Prog Brain Res; 2010; 182():229-53. PubMed ID: 20541668
[TBL] [Abstract][Full Text] [Related]
9. Dexamethasone down-regulates cAMP-phosphodiesterase in human osteosarcoma cells.
Ahlström M; Pekkinen M; Huttunen M; Lamberg-Allardt C
Biochem Pharmacol; 2005 Jan; 69(2):267-75. PubMed ID: 15627479
[TBL] [Abstract][Full Text] [Related]
10. Germline AIP mutations in apparently sporadic pituitary adenomas: prevalence in a prospective single-center cohort of 443 patients.
Cazabat L; Bouligand J; Salenave S; Bernier M; Gaillard S; Parker F; Young J; Guiochon-Mantel A; Chanson P
J Clin Endocrinol Metab; 2012 Apr; 97(4):E663-70. PubMed ID: 22319033
[TBL] [Abstract][Full Text] [Related]
11. Somatostatin analogs modulate AIP in somatotroph adenomas: the role of the ZAC1 pathway.
Chahal HS; Trivellin G; Leontiou CA; Alband N; Fowkes RC; Tahir A; Igreja SC; Chapple JP; Jordan S; Lupp A; Schulz S; Ansorge O; Karavitaki N; Carlsen E; Wass JA; Grossman AB; Korbonits M
J Clin Endocrinol Metab; 2012 Aug; 97(8):E1411-20. PubMed ID: 22659247
[TBL] [Abstract][Full Text] [Related]
12. The aryl hydrocarbon receptor-interacting protein gene is rarely mutated in sporadic GH-secreting adenomas.
Iwata T; Yamada S; Mizusawa N; Golam HM; Sano T; Yoshimoto K
Clin Endocrinol (Oxf); 2007 Apr; 66(4):499-502. PubMed ID: 17371465
[TBL] [Abstract][Full Text] [Related]
13. AIP mutations and gigantism.
Rostomyan L; Potorac I; Beckers P; Daly AF; Beckers A
Ann Endocrinol (Paris); 2017 Jun; 78(2):123-130. PubMed ID: 28483363
[TBL] [Abstract][Full Text] [Related]
14. Analysis of GPR101 and AIP genes mutations in acromegaly: a multicentric study.
Ferraù F; Romeo PD; Puglisi S; Ragonese M; Torre ML; Scaroni C; Occhi G; De Menis E; Arnaldi G; Trimarchi F; Cannavò S
Endocrine; 2016 Dec; 54(3):762-767. PubMed ID: 26815903
[TBL] [Abstract][Full Text] [Related]
15. Mutations in the aryl hydrocarbon receptor interacting protein gene are not highly prevalent among subjects with sporadic pituitary adenomas.
Barlier A; Vanbellinghen JF; Daly AF; Silvy M; Jaffrain-Rea ML; Trouillas J; Tamagno G; Cazabat L; Bours V; Brue T; Enjalbert A; Beckers A
J Clin Endocrinol Metab; 2007 May; 92(5):1952-5. PubMed ID: 17299063
[TBL] [Abstract][Full Text] [Related]
16. Molecular diagnosis of pituitary adenoma predisposition caused by aryl hydrocarbon receptor-interacting protein gene mutations.
Georgitsi M; Raitila A; Karhu A; Tuppurainen K; Mäkinen MJ; Vierimaa O; Paschke R; Saeger W; van der Luijt RB; Sane T; Robledo M; De Menis E; Weil RJ; Wasik A; Zielinski G; Lucewicz O; Lubinski J; Launonen V; Vahteristo P; Aaltonen LA
Proc Natl Acad Sci U S A; 2007 Mar; 104(10):4101-5. PubMed ID: 17360484
[TBL] [Abstract][Full Text] [Related]
17. Aryl hydrocarbon receptor-interacting protein gene mutations in familial isolated pituitary adenomas: analysis in 73 families.
Daly AF; Vanbellinghen JF; Khoo SK; Jaffrain-Rea ML; Naves LA; Guitelman MA; Murat A; Emy P; Gimenez-Roqueplo AP; Tamburrano G; Raverot G; Barlier A; De Herder W; Penfornis A; Ciccarelli E; Estour B; Lecomte P; Gatta B; Chabre O; Sabaté MI; Bertagna X; Garcia Basavilbaso N; Stalldecker G; Colao A; Ferolla P; Wémeau JL; Caron P; Sadoul JL; Oneto A; Archambeaud F; Calender A; Sinilnikova O; Montañana CF; Cavagnini F; Hana V; Solano A; Delettieres D; Luccio-Camelo DC; Basso A; Rohmer V; Brue T; Bours V; Teh BT; Beckers A
J Clin Endocrinol Metab; 2007 May; 92(5):1891-6. PubMed ID: 17244780
[TBL] [Abstract][Full Text] [Related]
18. No evidence of somatic aryl hydrocarbon receptor interacting protein mutations in sporadic endocrine neoplasia.
Raitila A; Georgitsi M; Karhu A; Tuppurainen K; Mäkinen MJ; Birkenkamp-Demtröder K; Salmenkivi K; Orntoft TF; Arola J; Launonen V; Vahteristo P; Aaltonen LA
Endocr Relat Cancer; 2007 Sep; 14(3):901-6. PubMed ID: 17914118
[TBL] [Abstract][Full Text] [Related]
19. Mutations of the gene for the aryl hydrocarbon receptor-interacting protein in pituitary adenomas.
Cazabat L; Guillaud-Bataille M; Bertherat J; Raffin-Sanson ML
Horm Res; 2009; 71(3):132-41. PubMed ID: 19188737
[TBL] [Abstract][Full Text] [Related]
20. Germline inactivating mutations of the aryl hydrocarbon receptor-interacting protein gene in a large cohort of sporadic acromegaly: mutations are found in a subset of young patients with macroadenomas.
Cazabat L; Libè R; Perlemoine K; René-Corail F; Burnichon N; Gimenez-Roqueplo AP; Dupasquier-Fediaevsky L; Bertagna X; Clauser E; Chanson P; Bertherat J; Raffin-Sanson ML
Eur J Endocrinol; 2007 Jul; 157(1):1-8. PubMed ID: 17609395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
